Flinton Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Flinton Capital Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$423K	Hold	6,813	–	–	0.01%	493
2019 Q2	$485K	Buy	6,813 +654	+11%	+$48.2K	0.02%	480
2019 Q1	$483K	Hold	6,159	–	–	0.02%	469
2018 Q4	$521K	Hold	6,159	–	–	0.02%	408
2018 Q3	$1.05M	Buy	6,159 +164	+3%	+$24.7K	0.03%	312
2018 Q2	$775K	Hold	5,995	–	–	0.03%	352
2018 Q1	$618K	Hold	5,995	–	–	0.02%	369
2017 Q4	$512K	Buy	5,995 +1,308	+28%	+$113K	0.02%	422
2017 Q3	$398K	Buy	4,687 +926	+25%	+$73.3K	0.01%	440
2017 Q2	$285K	Buy	3,761 +1,744	+86%	+$122K	0.01%	495
2017 Q1	$133K	Buy	2,017 +382	+23%	+$25.1K	0.01%	575
2016 Q4	$104K	Buy	+1,635	New	+$103K	﹤0.01%	588

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Flinton Capital Management's LGND Position: Q3 2019 in Review

Flinton Capital Management held its Ligand Pharmaceuticals (LGND) position steady in Q3 2019 at 6,813 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #493.

Flinton Capital Management first reported a position in LGND in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.05M in Q3 2018. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

Flinton Capital Management held 6,813 shares of Ligand Pharmaceuticals worth $423K as of Q3 2019.
Flinton Capital Management left its Ligand Pharmaceuticals share count unchanged in Q3 2019.
Ligand Pharmaceuticals made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #493 holding.
Flinton Capital Management first reported a position in Ligand Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Ligand Pharmaceuticals position peaked at $1.05M in Q3 2018.
275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.